Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma is a pharmaceutical company based in Japan.
Business Model:
Revenue: $0
Employees: 5,001-10,000
Rankings
Industries / Tags:
Detailed Dainippon Sumitomo Pharma Information
Geographic Data
Address:
City: Osaka
State: Osaka
Zip:
Country: Japan
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
"Green Prism", the symbol of Dainippon Sumitomo Pharma Co., Ltd. is a motif in the design of the "Sun"-expressing a lively sense of energy, moving on toward tomorrow; "Light"-to convey the potential and hope of the future; and "Flower"-engendering the joyous and liberated sensation of basking in good health. A design crafted to embody preeminent research and development powers, a thorough support system, the spirit of challenge, and the other stances of Dainippon Sumitomo Pharma-a company bent on supplying all people with the strength to push on toward an even brighter tomorrow. Emanating from the symbol, furthermore, is the image of a network, steadily spreading out into the world.
Contact Phone:
Contact Email:
Dainippon Sumitomo Pharma went public on 5/16/1949 on the TYO
Listed Exchange:
TYO
IPO Date:
5/16/1949
Ticker Symbol:
4506
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2014 | Create Vaccine | Venture Round | 0 |
| 4/2019 | AlphaNavi Pharma | Series A | 8.1M |
| 7/2019 | Drawbridge Health | Debt Financing | - |
| 3/2014 | Edison Pharmaceuticals | Venture Round | 0 |
| 10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
| 10/2018 | Meltin MMI | Series B | 0 |
| 8/2020 | Myovant Sciences | Post-IPO Debt | 0 |
| 10/2018 | FunPep | Venture Round | 0 |
| 10/2013 | Healios | Venture Round | 0 |
| 10/2021 | Roivant Sciences | Post-IPO Equity | 0 |
| 8/2020 | Myovant Sciences | Post-IPO Debt | 0 |
| 7/2019 | Drawbridge Health | Debt Financing | - |
| 4/2019 | AlphaNavi Pharma | Series A | 0 |
| 10/2018 | Meltin MMI | Series B | 0 |
| 10/2018 | FunPep | Venture Round | 0 |
| 5/2014 | Create Vaccine | Venture Round | 0 |
| 3/2014 | Edison Pharmaceuticals | Venture Round | 0 |
| 10/2013 | Healios | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 12/2016 | Tolero Pharmaceuticals | |
| 2/2012 | Boston Biomedical | |
| 9/2009 | Sunovion Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
